News & Updates
Excerpt from the Article: Though Philadelphia ranked second in a recent list of best cities for STEM diversity, but there’s still plenty of work to do to ensure underrepresented groups have access to the industry that so often spells prosperity for its workers. We’ve seen a number of efforts start up in the past few…
Read More
Excerpt from the Press Release: SAN DIEGO, Aug. 14, 2020 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today that in response to Adamis’ Pre-Investigational New Drug (IND) filing with the U.S. Food and Drug Administration (FDA), the FDA has provided detailed comments regarding the prospective use of Tempol in a randomized placebo…
Read More
Excerpt from the Press Release: OTTAWA, Ontario & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Variation Biotechnologies Inc., an Ottawa-based wholly-owned Canadian subsidiary of VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that it has been awarded up to a CAD$56 million contribution from the Strategic Innovation Fund of…
Read More
Excerpt from the Press Release: SAN DIEGO, Aug. 6, 2020 /PRNewswire/ — Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients with cancer, and Aegea Biotechnologies, Inc., an innovative private life science company with an extensive portfolio of issued patents…
Read More
Excerpt from the Press Release: SOUTH SAN FRANCISCO, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (“BBB”) for treatment of neurodegenerative diseases, today announced that DNL151 has been selected to progress into late stage studies…
Read More
Excerpt from the Article: It was purely by chance that at the very moment Ala Stanford walked into a revival service at a Philly church last summer, a man fainted and was suddenly unable to move or speak. Frantic and afraid, the man’s wife, a friend of Stanford’s, asked the board-certified surgeon to ride in…
Read More Excerpt from the Article: BC Children’s Hospital is pleased to congratulate the recipients of the 2020 BCCHR Studentships and Fellowships. These awards give exceptional trainees the opportunity to pursue leading-edge child health research projects under the supervision of BC Children’s Hospital Investigators. BCCHR Studentships and Fellowships are made possible through the support of BC Children’s…
Read More
Excerpt from the Press Release: Burlingame, CA, August 10, 2020 – Humanigen, Inc., (HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating cytokine storm with lenzilumab, the company’s proprietary Humaneered® anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody, announced that the Brazilian regulatory agency, Anvisa, has granted permission to commence a Phase…
Read More
Excerpt from the article: Convalescent therapy has been touted as a fast, effective response to COVID-19, but a new therapy by GigaGen Inc. could be even more promising. GIGA-2050, a new class of drug called a recombinant hyperimmune, offers 100-fold higher potency than convalescent serum therapy. “GIGA-2050 is a mix of 12,500 different antibody sequences…
Read More
Excerpt from the Article: “In April, San Diego’s Dexcom saw a slowdown in patients signing up for its continuous glucose monitors as consumers hunkered down and doctors transitioned to tele-medicine because of the COVID-19 pandemic. The question was how long would the dip last? As it turned out, not very long. As physicians and patients…
Read MoreRequest Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?